Eli Lilly & Co. (LLY)
1080.36
+5.68
(+0.53%)
USD |
NYSE |
Jan 02, 16:00
1079.00
-1.36
(-0.13%)
Pre-Market: 20:00
Eli Lilly Market Cap: 966.94B for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 176.43B |
| Regeneron Pharmaceuticals, Inc. | 81.59B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 4.004B |
| Moderna, Inc. | 12.06B |
Market Cap Related Metrics
| PE Ratio | 53.43 |
| PS Ratio | 16.58 |
| PEG Ratio | 0.4409 |
| Price to Book Value | 40.64 |
| Price to Free Cash Flow | 153.03 |
| Price | 1080.36 |
| Earnings Yield | 1.87% |
| PEGY Ratio | 0.4389 |
| Operating PE Ratio | 37.32 |
| Normalized PE Ratio | 47.85 |